regramostim: Clinical Trials

5 trials of regramostim, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Unknown 2
Phase 21Unknown 1

Follow regramostim: new trials by email Literature Review of regramostim trials Research Report on regramostim

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites
Serplulimab, Molgramostim, Hypofractionated radiotherapy/Sterotactic body radiotherapy - Malignant Ascites
Phase 1 / Phase 2UnknownSecond Affiliated Hospital of Soochow University402022-09-012022-08-15
A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma
Peptide, Anti-PD-1, rhGM-CSF - Melanoma (Skin)
Phase 1UnknownXiangya Hospital of Central South University302020-04-212020-04-28
A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF
pTVG-AR, gm-csf - Prostate Cancer
Phase 1CompletedUniversity of Wisconsin, Madison402015-08-242021-02-04
Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
Molgramostim, Placebo - Pulmonary Alveolar Proteinosis, Bronchiectasis
Phase 1CompletedSavara Inc.422015-05-012017-02-23
Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer
pTVG-HP with rhGM-CSF - Prostate Cancer
Phase 1CompletedUniversity of Wisconsin, Madison222005-03-012019-11-19

Conditions studied

Prostatic Neoplasms (2)  ·  Bronchiectasis (1)  ·  Cystic Fibrosis (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pulmonary Alveolar Proteinosis (1)  ·  Respiratory Distress Syndrome (1)

Sponsors

University of Wisconsin, Madison (2)  ·  Savara Inc. (1)  ·  Second Affiliated Hospital of Soochow University (1)  ·  Xiangya Hospital of Central South University (1)

Countries

United States (2)  ·  China (1)  ·  United Kingdom (1)

Top investigators

Douglas G. McNeel, M.D., Ph.D. (1)  ·  Douglas McNeel, MD (1)  ·  Johnston Steward, MD (1)  ·  Xiang Chen, Doctor's (1)

Results publications

PMID 28678778, PMID 28678784, PMID 28716080, PMID 32513836, PMID 39208856, PMID 40973220